PhD Thesis Presentation-2017.pdf (original) (raw)
A multifaceted approach to RSV vaccination
Trudy Morrison
Human vaccines & immunotherapeutics, 2018
View PDFchevron_right
Respiratory syncytial virus vaccines
robert dudas
1998
View PDFchevron_right
DNA vaccine RSV G (2018)
Haitham Amer
Acta virologica, 2018
View PDFchevron_right
Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines
Arne Ohlsson
Vaccine, 2001
View PDFchevron_right
Evaluation of a Live, Cold‐passaged, Temperature‐sensitive, Respiratory Syncytial Virus Vaccine Candidate In Infancy
ROBERT BELSHE
The Journal of …, 2000
View PDFchevron_right
Advances in RSV vaccine research and development – A global agenda
cheryl keech
Vaccine, 2016
View PDFchevron_right
New insights for development of a safe and protective RSV vaccine
Stefanie Vogel
Human Vaccines, 2010
View PDFchevron_right
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
ROBERT BELSHE
Journal of Infectious …, 2005
View PDFchevron_right
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus–associated Illness in Young Children
Coleen Cunningham
American Journal of Respiratory and Critical Care Medicine, 2021
View PDFchevron_right
Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV) A meeting report of the WHO Programme for Vaccine Development
James Crowe
Vaccine, 1995
View PDFchevron_right
Virus vs. virus: adenovirus vectored vaccine to defeat respiratory syncytial virus
Alessandra Vitelli
Annals of Translational Medicine
View PDFchevron_right
A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
Charles Stauft
Vaccine, 2020
View PDFchevron_right
Evaluation of Two Live, Cold‐Passaged, Temperature‐Sensitive Respiratory Syncytial Virus Vaccines in Chimpanzees and in Human Adults, Infants, and Children
James Crowe
The Journal of Infectious Diseases, 1997
View PDFchevron_right
Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
Carlotta Biagi
Vaccines, 2020
View PDFchevron_right
Live-Attenuated Respiratory Syncytial Virus Vaccines
Jennifer Oliva
Current Topics in Microbiology and Immunology, 2013
View PDFchevron_right
Respiratory syncytial virus (RSV) vaccines—Two steps back for one leap forward
Ultan Power
Journal of Clinical Virology, 2008
View PDFchevron_right
Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development
Afke Brandenburg
Vaccine, 2001
View PDFchevron_right
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Fu-Shi Quan
The Journal of Infectious Diseases, 2011
View PDFchevron_right
IMMUNIZATION AGAINST RSV BY GENETIC DELIVERY OF AN ANTI-RSV ANTIBODY.: 155
Chani Traube
Critical Care Medicine, 2006
View PDFchevron_right
Ongoing developments in RSV prophylaxis: a clinician’s analysis
Terri Harford
Current Opinion in Virology, 2017
View PDFchevron_right
Development of Novel Recombinant DNA Vaccine Candidates to Human Respiratory Syncytial Viruses
Mohamed Ali
View PDFchevron_right
Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner?
Tracy Hussell
Current Opinion in Microbiology, 1999
View PDFchevron_right
Human and bovine respiratory syncytial virus vaccine research and development
François SCHELCHER
Comparative Immunology, Microbiology and Infectious Diseases, 2008
View PDFchevron_right
Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates
Angiolo Pierantoni, Stefano Colloca, Geraldine Taylor, Alessandra Vitelli
Molecular Therapy — Methods & Clinical Development, 2015
View PDFchevron_right
The changing face of virology: will the application of molecular techniques inevitably lead to new and better vaccines?
Gregory A Tannock
Expert Review of Anti-infective Therapy, 2004
View PDFchevron_right
First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults
Michel Janssens
Clinical Infectious Diseases
View PDFchevron_right
Immunogenicity and Safety of Respiratory Syncytial Virus Subunit Vaccine in Seropositive Children 18-36 Months Old
Robert Welliver
Journal of Infectious Diseases, 1993
View PDFchevron_right
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
Bart Jones
Vaccine, 2012
View PDFchevron_right
An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children
Igor Rudan
BMC Public Health, 2011
View PDFchevron_right
Next Generation Vaccines for Infectious Diseases
Giuseppe Andrea Sautto, Criscuolo Elena
Journal of Immunology Research, 2019
View PDFchevron_right
Advances in and the potential of vaccines for respiratory syncytial virus
Ralph Tripp
Expert review of respiratory medicine, 2013
View PDFchevron_right